Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Maxpro Capital Acquisition (JMAC)

Maxpro Capital Acquisition Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:JMAC
DateTimeSourceHeadlineSymbolCompany
10/04/202313:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:JMACMaxpro Capital Acquisition Corporation
31/03/202320:01Edgar (US Regulatory)Annual Report (10-k)NASDAQ:JMACMaxpro Capital Acquisition Corporation
30/03/202312:10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JMACMaxpro Capital Acquisition Corporation
30/03/202312:00GlobeNewswire Inc.Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on NasdaqNASDAQ:JMACMaxpro Capital Acquisition Corporation
29/03/202321:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:JMACMaxpro Capital Acquisition Corporation
29/03/202321:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:JMACMaxpro Capital Acquisition Corporation
29/03/202320:25Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:JMACMaxpro Capital Acquisition Corporation
29/03/202320:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:JMACMaxpro Capital Acquisition Corporation
21/03/202320:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JMACMaxpro Capital Acquisition Corporation
14/02/202321:56Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:JMACMaxpro Capital Acquisition Corporation
13/02/202321:08Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:JMACMaxpro Capital Acquisition Corporation
10/02/202312:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JMACMaxpro Capital Acquisition Corporation
13/01/202321:34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JMACMaxpro Capital Acquisition Corporation
13/01/202321:13GlobeNewswire Inc.Maxpro Capital Acquisition Corp. Confirms Additional Funding and Extension of Deadline to Complete Initial Business CombinationNASDAQ:JMACMaxpro Capital Acquisition Corporation
10/01/202321:32Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:JMACMaxpro Capital Acquisition Corporation
10/01/202321:24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JMACMaxpro Capital Acquisition Corporation
10/01/202321:05GlobeNewswire Inc.Maxpro Capital Acquisition Corp. Announces Extension to Deadline to Complete Business CombinationNASDAQ:JMACMaxpro Capital Acquisition Corporation
15/11/202213:00GlobeNewswire Inc.Apollomics Inc. Receives FDA Orphan Drug Designation for Vebreltinib (APL-101) for Treatment of Non-Small Cell Lung Cancer with MET Genomic Tumor AberrationsNASDAQ:JMACMaxpro Capital Acquisition Corporation
14/10/202220:59Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JMACMaxpro Capital Acquisition Corporation
14/10/202220:54GlobeNewswire Inc.Maxpro Capital Acquisition Corp. Confirms Additional Funding and Extension of Deadline to Complete Initial Business CombinationNASDAQ:JMACMaxpro Capital Acquisition Corporation
07/10/202220:22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JMACMaxpro Capital Acquisition Corporation
07/10/202220:05GlobeNewswire Inc.Maxpro Capital Acquisition Corp. Announces Extension to Deadline to Complete Business CombinationNASDAQ:JMACMaxpro Capital Acquisition Corporation
15/09/202210:22Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:JMACMaxpro Capital Acquisition Corporation
14/09/202216:04Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:JMACMaxpro Capital Acquisition Corporation
14/09/202216:04Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:JMACMaxpro Capital Acquisition Corporation
14/09/202216:03Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:JMACMaxpro Capital Acquisition Corporation
14/09/202212:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JMACMaxpro Capital Acquisition Corporation
14/09/202212:30GlobeNewswire Inc.Apollomics Inc., a Late-Stage Clinical Biopharmaceutical Company to be Listed on Nasdaq Through Business Combination with Maxpro Capital Acquisition Corp.NASDAQ:JMACMaxpro Capital Acquisition Corporation
14/02/202221:15Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:JMACMaxpro Capital Acquisition Corporation
13/01/202221:06Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:JMACMaxpro Capital Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:JMAC

Your Recent History

Delayed Upgrade Clock